ImmunoCellular Therapeutics
Montvale, US
Biotech
Founders & leadership
FD
Frank DouglasDirector
JK
Julie KampfDirector
RL
Robert LehmanDirector
EG
Eli GoldbergerExecutive Officer, Director
WD
Wayne DansonExecutive Officer
IT
Irach TaraporewalaExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements▶$750KraisedSep 2022 · 1 investors · PharmaceuticalsRule 506(b)
▶$750KraisedSep 2022 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Frank DouglasDirector
- Julie KampfDirector
- Robert LehmanDirector
- Eli GoldbergerExecutive Officer, Director
- Wayne DansonExecutive Officer
- Irach TaraporewalaExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $750K
- Minimum investment
- $25K
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.